Dr. Liu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1810 116th Ave NE
Ste 100
Bellevue, WA 98004Phone+1 425-455-2275Fax+1 425-455-1511
Education & Training
University of Utah HealthResidency, Dermatology, 2000 - 2003
University of California San Francisco School of MedicineFellowship, 1999 - 2000
Tulane UniversityInternship, Internal Medicine, 1998 - 1999
New York University School of MedicineClass of 1998
Certifications & Licensure
CA State Medical License 1999 - Present
WA State Medical License 2004 - 2026
UT State Medical License 2000 - 2006- American Board of Dermatology Dermatology
Awards, Honors, & Recognition
- Fellow (FAAD) American Academy of Dermatology
Clinical Trials
- Trial Evaluating the Efficacy of Apremilast for the Treatment of Frontal Fibrosing Alopecia Start of enrollment: 2018 Jul 12
Roles: Principal Investigator, Contact, Study Director
Publications & Presentations
PubMed
- 8 citationsImpact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis in the United States: A Multicenter Observationa...Phillip Mease, Clive Liu, Evan L. Siegel, Heather M. Richmond, Meijing Wu
American Journal of Clinical Dermatology. 2019-12-01 - 13 citationsMalignancy Rates in Brodalumab Clinical Studies for PsoriasisAlice B. Gottlieb, Mark Lebwohl, Clive Liu, Robert J. Israel, Abby Jacobson
American Journal of Clinical Dermatology. 2020-06-01 - 7 citationsBrodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to Biologics.Alan Menter, April W. Armstrong, Abby S. Van Voorhees, Clive Liu, Abby Jacobson
Dermatology and Therapy. 2020-06-12
Press Mentions
Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to BiologicsJune 12th, 2020
COSENTYX (Secukinumab) for the Ongoing Management of Adult Patients with Moderate to Severe Plaque Psoriasis and Active Psoriatic ArthritisDecember 7th, 2017
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
